Full Download Apolipoprotein A-I amyloidogenic variant L174S, expressed and isolated from stably transfected mammalian cells, is associated with fatty acids - D M Monti; S D Gaetano; R D Giudice; C Giangrande; A Amoresano; All authors | ePub
Related searches:
Mechanisms of aggregation and fibril formation of the amyloidogenic
Apolipoprotein A-I amyloidogenic variant L174S, expressed and isolated from stably transfected mammalian cells, is associated with fatty acids
Structure, function and amyloidogenic propensity of apolipoprotein A-I
Hereditary amyloidosis with progressive peripheral neuropathy
Hepatic amyloidosis resulting from deposition of the apolipoprotein
Novel clinical manifestations and treatment of hereditary apoA-I
Amyloidogenic Modifications of Apolipoprotein AI Promote a Strong
Human Apolipoprotein A-I-Derived Amyloid: Its Association with
Lipoproteins and amyloid vascular disease : Current Opinion in
The fibrillogenic L178H variant of apolipoprotein A-I forms helical
Apolipoprotein A1, the neglected relative of Apolipoprotein E and its
APOA1 related amyloidosis: A case report and literature - CiteSeerX
2129 4358 4890 4635 1173 2526 3119 3365 2360 1941 4643 2236 4435 3811 1192 4334 1541 4567
Feb 2, 2010 apolipoprotein a-i (apoa-i) is the major protein component of hdl, where it plays an important role in cholesterol transport.
The diagnostics of apolipoprotein a-i amyloidosis, optimizes its treatment, and expands our understanding of the molecular basis of this multipronged disease.
Aβ crosses the blood–brain barrier with the assistance of apo a-i on the interior side and apo j on the plasma interface.
In addition to light chain amyloidosis, there are a number of acquired amyloidoses caused by the misfolding and precipitation of a wide variety of proteins.
The positive side of the alzheimer's disease amyloid cross-interactions: the case of the aβ 1-42 peptide with tau, ttr, cysc, and apoa1.
In apo ai amyloidosis, the indices cases diagnosis requires high clinical suspicion and a renal medulla biopsy is important to observe the amyloid deposit at this.
Nov 18, 2011 amyloidogenic apolipoprotein a-i variants: a possible impact on the natural history of the disease.
Defects in this gene are associated with hdl deficiencies, including tangier disease, and with systemic non-neuropathic amyloidosis.
Jun 22, 2018 hereditary apoa-i amyloidosis (aapoai) is a rare monogenic disease wherein specific mutations in the apoa1 gene cause abnormal amyloid.
Sep 6, 2019 the n-terminal (1–83) fragment of the major constituent of plasma high-density lipoprotein, apolipoprotein a-i (apoa-i), strongly tends to form.
Jun 28, 2007 systemic amyloidosis associated with hereditary variant apolipoprotein ai (apoai ) is a rare autosomal‐dominant condition in which widespread.
Nonhereditary apolipoprotein a-i (apoa-i) amyloid is characterized by deposits of nonvariant protein in atherosclerotic arteries.
A number of amyloidogenic variants of apoa-i have been discovered but most have not been analyzed.
Feb 10, 2020 apolipoprotein e4 (also known as apoe4) is the most prevalent genetic α- synuclein pathology and related toxicity independent of amyloid.
Apolipoprotein a-i amyloidosis (aapo a-i) is an inherited jystemic disease that results fiom pathologic deposition in tissues of fibrils composed of apo a-i-related.
Post Your Comments: